See The Weight-Loss Price Wars Are Breaking Big Pharma’s Business Model: Prices for GLP-1s are falling fast and forcing companies to adapt by David Wainer of The WSJ.”Two years ago, a GLP-1 prescription could cost an uninsured patient more than $1,000 a month. Today, Novo Nordisk’s Wegovy pill starts at just $149 through cash-pay programs.””Typically, drug…
Competition, elasticity and weight-loss drugs
Competition, elasticity and weight-loss drugs
27 Feb 2026 Leave a comment
in applied price theory, health economics, industrial organisation
Recent Comments